“…Research has shown that IL2 [452], IGFBP3 [70], ENPP1 [453], FASLG (Fas ligand) [454], FAP (fibroblast activation protein alpha) [455], IFNG (interferon gamma) [456], AKT3 [457], BMPR1A [458], SPRY1 [459], ANXA1 [460], PTCH1 [461], IGF2 [462], MMP9 [463], HP (haptoglobin) [464], GDF15 [465], KCNMA1 [466], ACE2 [467], TRPV4 [468], ADM (adrenomedullin) [469], CD274 [470], IGFBP2 [471], SOCS3 [472], TREM2 [473], CAV1 [474], PROK2 [475], MAPK14 [476] and CDKN1A [477] plays an important role in the pathogenesis of osteoporosis. Studies have revealed that IL2 [478], ENPP1 [479], FASLG (Fas ligand) [480], FAP (fibroblast activation protein alpha) [481], BIRC3 [482], IFNG (interferon gamma) [483], NCR1 [484], RAG1 [485], SEMA3A [486], TIGIT (T cell immunoreceptor with Ig and ITIM domains) [487], CD19 [488], TGFBR3 [489], IL5 [490], MMP9 [491], HP (haptoglobin) [492], GDF15 [493], ACE2 [494], DYSF (dysferlin) [495], IL27 [496], CAV1…”